Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A09668 | 31652837 | Cancers (Basel) | Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer. | 2019 | Details |
| A09669 | 31652761 | Nutrients | Obesity in the Liver Transplant Setting. | 2019 | Details |
| A09670 | 31652636 | Cells | MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice. | 2019 | Details |
| A09673 | 31652512 | Nutrients | The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial. | 2019 | Details |
| A09676 | 31651666 | J Pediatr Gastroenterol Nutr | Community Socioeconomic Deprivation and Nonalcoholic Fatty Liver Disease Severity. | 2020 | Details |
| A09679 | 31651571 | J Clin Gastroenterol | The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2020 | Details |
| A09685 | 31649787 | Prz Gastroenterol | Non-alcoholic fatty liver disease in Poland: how and at what stage is diagnosed, and how is treated. A survey study. | 2019 | Details |
| A09686 | 31648561 | FASEB J | KLF15-activating Twist2 ameliorated hepatic steatosis by inhibiting inflammation and improving mitochondrial dysfunction via NF-κB-FGF21 or SREBP1c-FGF21 pathway. | 2019 | Details |
| A09687 | 31647808 | PLoS Genet | Causal relationships between obesity and the leading causes of death in women and men. | 2019 | Details |
| A09688 | 31647137 | J Ultrasound Med | Ultrasound Fatty Liver Indicator: A Simple Tool for Differentiating Steatosis From Nonalcoholic Steatohepatitis: Validity in the Average Obese Population. | 2019 | Details |
| A09689 | 31646850 | Minerva Gastroenterol Dietol | Non-alcoholic fatty liver disease: a survey of involvement of primary care physicians. | 2019 | Details |
| A09697 | 31642599 | HIV Med | Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients. | 2019 | Details |
| A09699 | 31641249 | Nat Rev Gastroenterol Hepatol | Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology. | 2019 | Details |
| A09705 | 31638270 | Clin Pharmacol Ther | Acetaminophen-Induced Liver Damage in Hepatic Steatosis. | 2019 | Details |
| A09708 | 31637675 | J Endocrinol Invest | High uric acid, reduced glomerular filtration rate and non-alcoholic fatty liver in young people with obesity. | 2019 | Details |
| A09709 | 31637670 | Obes Surg | What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)? | 2020 | Details |
| A09714 | 31635469 | Vnitr Lek | Serum markers in diagnostics of steatohepatitis. | 2019 | Details |
| A09715 | 31635468 | Vnitr Lek | Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A09723 | 31633724 | Arq Gastroenterol | A STUDY OF METABOLIC PARAMETERS IN NON DIABETIC PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE - IMPORTANCE OF DYSLIPIDEMIA. | 2019 | Details |
| A09724 | 31633721 | Arq Gastroenterol | EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS. | 2019 | Details |
| A09730 | 31632525 | Am J Transl Res | Neuregulin 4 attenuate tubulointerstitial fibrosis and advanced glycosylation end products accumulation in diabetic nephropathy rats via regulating TNF-R1 signaling. | 2019 | Details |
| A09731 | 31632457 | Therap Adv Gastroenterol | Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density fat fraction. | 2019 | Details |
| A09735 | 31631714 | Curr Med Res Opin | Hepatocellular carcinoma in non-alcohol fatty liver disease - changing trends and specific challenges. | 2019 | Details |
| A09738 | 31630897 | Trends Endocrinol Metab | NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin? | 2019 | Details |
| A09743 | 31629366 | Endocr Rev | Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management. | 2020 | Details |
| A09744 | 31628998 | Clin Gastroenterol Hepatol | Decreased Physical Working Capacity in Adolescents With Nonalcoholic Fatty Liver Disease Associates With Reduced Iron Availability. | 2019 | Details |
| A09754 | 31623368 | Nutrients | Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study. | 2019 | Details |
| A09760 | 31621579 | Elife | Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease. | 2019 | Details |
| A09763 | 31620616 | Yeungnam Univ J Med | Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology. | 2019 | Details |
| A09770 | 31616668 | Front Med (Lausanne) | Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review. | 2019 | Details |
| A09780 | 31613826 | Menopause | Comparison of anthropometric indices for the screening of nonalcoholic fatty liver disease in pre- and postmenopausal women. | 2020 | Details |
| A09794 | 31608220 | J Clin Transl Hepatol | Obesity Paradox in Chronic Liver Diseases: Product of Bias or a Real Thing? | 2019 | Details |
| A09798 | 31606352 | Ann Hepatol | Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know? | 2019 | Details |
| A09800 | 31604965 | Sci Rep | Depletion of CD40 on CD11c+ cells worsens the metabolic syndrome and ameliorates hepatic inflammation during NASH. | 2019 | Details |
| A09803 | 31604171 | Atherosclerosis | Visceral adipose tissue volume is associated with premature atherosclerosis in early type 2 diabetes mellitus independent of traditional risk factors. | 2019 | Details |
| A09804 | 31604107 | Life Sci | Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. | 2019 | Details |
| A09809 | 31602167 | World J Gastroenterol | Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history. | 2019 | Details |
| A09811 | 31601229 | Trials | Effect of probiotic supplementation in nonalcoholic steatohepatitis patients: PROBILIVER TRIAL protocol. | 2019 | Details |
| A09812 | 31601203 | BMC Endocr Disord | Prevalence of cardiovascular risk factors in non-menopausal and postmenopausal inpatients with type 2 diabetes mellitus in China. | 2019 | Details |
| A09814 | 31600750 | Digestion | Rodent Models of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09815 | 31599882 | Rev Invest Clin | INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-1, NON-ALCOHOLIC FATTY LIVER DISEASE, AND ITS RELATIONSHIP WITH FRUCTOSE CONSUMPTION IN CHILDREN WITH OBESITY. | 2019 | Details |
| A09816 | 31599742 | Am J Gastroenterol | The Impact of Obesity and Type 2 Diabetes on Chronic Liver Disease. | 2019 | Details |
| A09818 | 31599067 | Mol Nutr Food Res | Mastiha (Pistacia lentiscus) Improves Gut Microbiota Diversity, Hepatic Steatosis, and Disease Activity in a Biopsy-Confirmed Mouse Model of Advanced Non-Alcoholic Steatohepatitis and Fibrosis. | 2019 | Details |
| A09825 | 31597607 | Trends Endocrinol Metab | Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09830 | 31595673 | EMBO Mol Med | Liver ASK1 protects from non-alcoholic fatty liver disease and fibrosis. | 2019 | Details |
| A09838 | 31594173 | Zhonghua Nei Ke Za Zhi | [Characteristics and clinical significance of body composition in gout patients]. | 2019 | Details |
| A09850 | 31592021 | Hepatol Commun | Novel Lipid Long Intervening Noncoding RNA, Oligodendrocyte Maturation-Associated Long Intergenic Noncoding RNA, Regulates the Liver Steatosis Gene Stearoyl-Coenzyme A Desaturase As an Enhancer RNA. | 2019 | Details |
| A09855 | 31590127 | Biomed Pharmacother | Nr2e1 ablation impairs liver glucolipid metabolism and induces inflammation, high-fat diets amplify the damage. | 2019 | Details |
| A09860 | 31588816 | Arch Physiol Biochem | The association between retinol-binding protein 4 and prediabetes in obese patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A09873 | 31581129 | Endocr Connect | Hyperinsulinaemia: does it tip the balance toward intrahepatic fat accumulation? | 2019 | Details |
| A09874 | 31580887 | Regul Toxicol Pharmacol | Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis. | 2019 | Details |
| A09876 | 31578240 | Sci Transl Med | Controlled-release mitochondrial protonophore (CRMP) reverses dyslipidemia and hepatic steatosis in dysmetabolic nonhuman primates. | 2019 | Details |
| A09882 | 31575546 | Cancer Res | HNF4α-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular Carcinoma. | 2019 | Details |
| A09884 | 31575419 | Am J Surg | Bariatric surgery is associated with reduction in non-alcoholic steatohepatitis and hepatocellular carcinoma: A propensity matched analysis. | 2019 | Details |
| A09886 | 31574533 | Carcinogenesis | Cyclin-like proteins tip regenerative balance in the liver to favour cancer formation. | 2020 | Details |
| A09887 | 31574313 | Clin Gastroenterol Hepatol | Performance of Simple Fibrosis Scores in Nonobese Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09891 | 31573042 | Int J Mol Med | Fatty liver and alteration of the gut microbiome induced by diallyl disulfide. | 2019 | Details |
| A09893 | 31572388 | Front Immunol | The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype. | 2019 | Details |
| A09898 | 31569521 | Molecules | Separation and Lipid Inhibition Effects of a Novel Decapeptide from Chlorella pyenoidose. | 2019 | Details |
| A09907 | 31566148 | Public Health Nutr | Adherence to the Dietary Approaches to Stop Hypertension (DASH) diet is associated with lower presence of non-alcoholic fatty liver disease in middle-aged and elderly adults. | 2019 | Details |
| A09909 | 31564942 | Diabetes Metab Syndr Obes | The interplay between abdominal aortic aneurysm, metabolic syndrome and fatty liver disease: a retrospective case-control study. | 2019 | Details |
| A09914 | 31562717 | J Assoc Physicians India | Development of Non-alcoholic Fatty Liver Disease (NAFLD) in Young Obese Tribal Subjects of Tripura: Link between Low 25 (OH) Vitamin-D Levels and Immune Modulators. | 2019 | Details |
| A09916 | 31562685 | J Hepatobiliary Pancreat Sci | Decrease in major secondary bile acid, hyodeoxycholic acid, was the main alteration in hepatic bile acid compositions in a hypertensive nonalcoholic fatty liver disease model. | 2019 | Details |
| A09920 | 31559605 | Hepatol Int | Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis. | 2019 | Details |
| A09922 | 31559105 | World J Gastrointest Pathophysiol | Overview of studies of the vitamin D/vitamin D receptor system in the development of non-alcoholic fatty liver disease. | 2019 | Details |
| A09923 | 31558861 | World J Gastroenterol | Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways. | 2019 | Details |
| A09926 | 31558407 | Surg Obes Relat Dis | Impact of a preoperative low-calorie diet on liver histology in patients with fatty liver disease undergoing bariatric surgery. | 2019 | Details |
| A09931 | 31555572 | Pediatr Gastroenterol Hepatol Nutr | Role of Soluble Adiponectin Receptor 2 in Non-Alcoholic Fatty Liver Disease in Children. | 2019 | Details |
| A09932 | 31555219 | Front Endocrinol (Lausanne) | Gut Dysfunction and Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A09933 | 31554932 | Nat Rev Endocrinol | The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state. | 2019 | Details |
| A09940 | 31553600 | J Chem Theory Comput | Molecular Dynamics Study of the Hybridization between RNA and Modified Oligonucleotides. | 2019 | Details |
| A09943 | 31551515 | Cell Mol Immunol | NLRP3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling. | 2019 | Details |
| A09946 | 31548878 | Cell Biosci | BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling. | 2019 | Details |
| A09947 | 31548436 | Aging (Albany NY) | KLB gene polymorphism is associated with obesity and non-alcoholic fatty liver disease in the Han Chinese. | 2019 | Details |
| A09949 | 31547555 | Nutrients | Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors. | 2019 | Details |
| A09950 | 31547124 | J Clin Med | Is There a Link between Basal Metabolic Rate, Spleen Volume and Hepatic Growth Factor Levels in Patients with Obesity-Related NAFLD? | 2019 | Details |
| A09958 | 31543468 | Ann Hepatol | Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis. | 2019 | Details |
| A09959 | 31543467 | Ann Hepatol | Obesity and liver cancer. | 2019 | Details |
| A09966 | 31541796 | Phytomedicine | Hepatoprotective and anti-inflammatory effects of total flavonoids of Qu Zhi Ke (peel of Citrus changshan-huyou) on non-alcoholic fatty liver disease in rats via modulation of NF-κB and MAPKs. | 2019 | Details |
| A09978 | 31538291 | Endocrine | Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. | 2019 | Details |
| A09980 | 31538216 | Herz | Cardiac abnormalities in patients with nonalcoholic fatty liver disease : Insights from auxiliary examinations. | 2019 | Details |
| A09981 | 31538123 | Arch Med Sci Atheroscler Dis | Comparison of clinical characteristics between lean and obese nonalcoholic fatty liver disease in the northeast Chinese population. | 2019 | Details |
| A09982 | 31537030 | Semin Liver Dis | Peculiarities of Cirrhosis due to Nonalcoholic Steatohepatitis (NASH). | 2019 | Details |
| A09986 | 31535735 | Nutr Clin Pract | Nonalcoholic Fatty Pancreas Disease. | 2019 | Details |
| A09987 | 31535207 | J Gastroenterol | Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis. | 2019 | Details |
| A09989 | 31534518 | Theranostics | Inhibition of HSP90β Improves Lipid Disorders by Promoting Mature SREBPs Degradation via the Ubiquitin-proteasome System. | 2019 | Details |
| A09992 | 31533345 | Medicina (Kaunas) | Relationship Between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients. | 2019 | Details |
| A09999 | 31530849 | Sci Rep | Controlling Obesity and Metabolic Diseases by Hydrodynamic Delivery of a Fusion Gene of Exendin-4 and α1 Antitrypsin. | 2019 | Details |
| A10002 | 31529722 | Hepatology | Hepatocyte ELOVL Fatty Acid Elongase 6 Determines Ceramide Acyl-Chain Length and Hepatic Insulin Sensitivity in Mice. | 2020 | Details |
| A10004 | 31529394 | Obes Surg | Non-Alcoholic Fatty Liver Disease Is Associated with Impairment of Ejection Fraction Among Individuals with Obesity Undergoing Bariatric Surgery: Results of a Cross-Sectional Study. | 2020 | Details |
| A10006 | 31528245 | World J Hepatol | Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice. | 2019 | Details |
| A10007 | 31527322 | J Atheroscler Thromb | Association of Fetuin-B with Subclinical Atherosclerosis in Obese Chinese Adults. | 2019 | Details |
| A10008 | 31526774 | Clin Chim Acta | Circulating ectodysplasin A is a potential biomarker for nonalcoholic fatty liver disease. | 2019 | Details |
| A10009 | 31526528 | J Pediatr | The Contribution of the Adipose Tissue-Liver Axis in Pediatric Patients with Nonalcoholic Fatty Liver Disease after Laparoscopic Sleeve Gastrectomy. | 2019 | Details |
| A10013 | 31524533 | Expert Opin Investig Drugs | Multi-drug approaches to NASH: what's in the development pipeline? | 2019 | Details |
| A10017 | 31523443 | BMJ Open Gastroenterol | Associations of chronic diarrhoea with non-alcoholic fatty liver disease and obesity-related disorders among US adults. | 2019 | Details |
| A10018 | 31523440 | BMJ Open Gastroenterol | Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in Russia. | 2019 | Details |
| A10020 | 31522189 | Am J Case Rep | Sugar and the Mosaic of Autoimmunity. | 2019 | Details |
| A10024 | 31520816 | J Nutr Biochem | Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy. | 2019 | Details |
| A10027 | 31520549 | Fundam Clin Pharmacol | Tanshinone IIA reduces palmitate-induced apoptosis via inhibition of endoplasmic reticulum stress in HepG2 liver cells. | 2019 | Details |